QPharma Launches Neolytica Healthcare Analytics Firm

In the US, life sciences sector medical, commercial and compliance company QPharma has set up Neolytica, an analytics business using techniques including natural language processing, AI, facial recognition and chat bots.

QPharma includes a Commercial Services division offering sample management and distribution, product launch management, online training, and HCP/KOL targeting and engagement; and a Professional Services team working on project management, auditing and training. The new Neolytica subsidiary will use technology for medical affairs / medial science liaison insights, marketing, and commercial teams.

QPharma President and CEO Patrick Den Boer (pictured) says the launch follows recent company innovations like sample direct to patient, sentiment analysis, and social media monitoring through the company's NotifyMe solution. He adds: 'Based on recent success of our health analytics solution, we are confident that Neolytica will act as a catalyst in the industry and address its need for insightful platforms and solutions'.

Web sites: www.qpharmacorp.com and www.neolytica.ai .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.